Social Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Social Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-14Clinical Trial Update: D-Cycloserine Enhancement of Exposure in Social Phobia [Phase 4]
A Phase 4 clinical trial tested whether D-Cycloserine can enhance exposure therapy for Social Anxiety Disorder; the study has completed and …
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Interpretation Modification Program for Social Phobia [NA]
This entry reports the completion and posting of results for a behavioral interpretation modification trial targeting Social Anxiety Disorde…
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Attention Disengagement Training for Social Phobia [NA]
This clinical trial update reports the completion of a study on attention disengagement training for Social Anxiety Disorder, with results p…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders [NA]
This clinical trial update reports the completion of a randomized study evaluating a brief, transdiagnostic therapy called False Safety Beha…
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Flushing in Social Anxiety Disorder on Seroquel [Phase 3]
A Phase 3 trial of quetiapine (Seroquel) for Social Anxiety Disorder has completed; the update centers on flushing as a reported side effect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-01-20Clinical Trial Update: Study of Vilazodone to Treat Social Anxiety Disorder [NA]
This document reports an update on a clinical trial evaluating vilazodone for social anxiety disorder, with the trial status not specified.
-
FDA approval · 2014-01-10FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc., authorizing its manufacturing and…
-
FDA approval · 2013-12-31FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for a generic paroxetine hydrochloride product manufactured by NorthStar Rx LLC.
-
FDA approval · 2013-12-31FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Paroxetine hydrochloride hemihydrate from Mylan Pharmaceuticals, confirming the continued author…
-
FDA approval · 2013-12-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Venlafaxine Hydrochloride by Aurobindo Pharma Limited, updating the regulatory status of thi…
-
FDA approval · 2013-12-19FDA Approved: PAROXETINE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for paroxetine submitted by Padagis US LLC (NDA 204516).
-
FDA approval · 2013-12-16FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride (generic sertraline), enabling a new generic versi…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type) [Phase 2]
Phase 2 trial evaluating the efficacy and safety of levetiracetam for social anxiety disorder (generalized type) has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: Nefazodone in the Treatment of Social Phobia [Phase 4]
A Phase 4 study evaluating nefazodone for social anxiety disorder has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety [Phase 3]
Phase 3 trial completed evaluating Yohimbine as an adjunct to Cognitive Behavioral Therapy for Social Anxiety Disorder. Results were posted …
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder [Phase 4]
Phase 4 clinical trial evaluating Gabitril (tiagabine) in patients with Social Anxiety Disorder has completed. No efficacy or safety results…
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia [Phase 2]
This document reports an open-label Phase 2 trial of an omega-3 fatty acid supplement (o3mega+Joy) for Social Anxiety Disorder, which has co…
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: Flushing in Social Anxiety Disorder on Cipralex [Phase 2]
Phase 2 clinical trial evaluating flushing in patients with Social Anxiety Disorder treated with escitalopram (Cipralex); the study has comp…
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder [Phase 4]
Phase 4 trial update reporting results on pharmacotherapy to improve treatment outcomes for social anxiety disorder.
-
FDA approval · 2013-09-26FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for ZOLOFT (sertraline hydrochloride) submitted by Roerig.
-
CLINICAL_TRIALS trial_result · 2013-08-01Clinical Trial Update: Treatment of Childhood Social Phobia [Phase 3]
A Phase 3 clinical trial evaluating treatment for childhood social phobia has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia [NA]
This clinical trial update reports the completion and posting of results for a study assessing assessment and treatment of social skills def…
-
FDA approval · 2013-06-28FDA Approved: PAROXETINE — Original Application (Padagis US LLC)
FDA approved a paroxetine product from Padagis US LLC under an original application.
-
CLINICAL_TRIALS trial_result · 2013-05-24Clinical Trial Update: Geodon for the Treatment of Refractory Social Anxiety Disorder [Phase 2]
Phase 2 trial of ziprasidone (Geodon) for refractory social anxiety disorder has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: Phased Treatment for Social Anxiety Disorder and Coping Behaviors in a Medical Setting [NA]
This completed clinical trial evaluated phased treatment approaches for social anxiety disorder and coping behaviors in a medical setting.